Skip to content
Home
Pipeline
Team
Press
Menu
Home
Pipeline
Team
Press
Pyramid Biosciences and GeneQuantum Healthcare Announce Preclinical Data for GQ1010, a Potential Best-In-Class TROP2-Targeted Antibody Drug Conjugate, at the 2023 AACR Annual Meeting